Drug Respiratory

Airsupra

Payments companies reported to CMS as associated with Airsupra. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$26Massociated payments (2023-2025)
80,987clinicians with associated payments
3companies reporting

By year

2023 $2.2M
2024 $12M
2025 $11M

Payments reported as associated with Airsupra, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Allergy & Immunology $6.4M
Pulmonary Disease $3.9M
Family Medicine $3.7M
Family $2.5M
Internal Medicine $2.4M
Allergy $1.3M

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Airsupra

These are the largest totals companies reported as associated with Airsupra. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Nina Ramirez Miami, FL Allergy & Immunology $323,965.21
Autumn Burnette Washington, DC Allergy & Immunology (Internal Medicine) $292,721.99
Joseph Diaz San Antonio, TX Allergy & Immunology $266,457.36
Gregory Bensch Stockton, CA $229,658.15
Susan Ratay Ashtabula, OH Family Medicine $204,934.93
Cedric Franklin Rutland Riverside, CA Critical Care Medicine (Internal Medicine) $203,088.79
Kevin Murphy Boys Town, NE Allergy & Immunology $200,908.70
Nathanael Brady Colorado Springs, CO Allergy $186,253.63
David Marks San Antonio, TX Pulmonary Disease $182,854.41
Brett Stanaland Naples, FL Allergy $181,938.57

Prescribed Airsupra?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.